2026 Maryland General ElectionNext Key Date: Voter Registration Deadline (Oct 13 • 31d)Polling Places & Deadlines
Early Voting:40 Days
Election Day:52 Days
Back to All 2026 Races
Keith SalkowskiPrimary Archive
DemocraticDid Not Advance to General ElectionDemocratic Primary• U.S. House of Representatives - Maryland District 5

Keith Salkowski

Montgomery County, MarylandCandidate for U.S. House of Representatives, MD-05
Did Not Advance to General Election • Historic Primary ArchiveNot on Nov 3 Ballot

Competed in the June 23, 2026 Democratic Primary Election and received 203 votes (0.2%). This candidate did not win the party nomination and will NOT appear on the November 3, 2026 General Election ballot.

Democratic candidate for U.S. House of Representatives District 5. Community advocate championing government accountability, consumer protection, and fiscal integrity.

No Campaign Website FoundCompare with Opponents

Mission & Aggregation Notice: Our mission is candidate information aggregation—helping Southern Maryland voters compare candidate stances side-by-side without digging through campaign websites, Facebook posts, and news articles. All content is aggregated from public sources.

Read Disclaimer

Always verify with primary sources: Official voting locations, rules, and candidate certifications must be verified directly with the St. Mary's County Board of Elections, Calvert County Board of Elections, or Maryland State Board of Elections.

Verified Policy Stances & Platform

Public record positions, statements, and campaign positions.

No verified policy statements or platform recorded yet

Our editorial research has not identified an active campaign website, social media presence, or public policy platform for this candidate in official filings or local press coverage to date.

Are you affiliated with this campaign or have official campaign materials? Submit verified platform positions to [email protected].

Official Campaign Priorities

  • Strengthening consumer financial protections against predatory lending practices
  • Ensuring stringent transparency and ethical standards for federal lawmakers
  • Supporting policies that lower healthcare and prescription medicine costs